Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $208,377 - $265,668
3,900 New
3,900 $240,000
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $36,491 - $65,667
700 Added 28.0%
3,200 $222,000
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $110,364 - $169,099
-1,700 Reduced 40.48%
2,500 $227,000
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $436,107 - $535,572
-5,700 Reduced 57.58%
4,200 $388,000
Q3 2021

Nov 12, 2021

BUY
$71.29 - $95.99 $434,869 - $585,539
6,100 Added 160.53%
9,900 $776,000
Q1 2021

May 14, 2021

BUY
$77.91 - $125.92 $116,865 - $188,880
1,500 Added 65.22%
3,800 $384,000
Q4 2020

Feb 12, 2021

BUY
$60.0 - $87.29 $138,000 - $200,767
2,300 New
2,300 $200,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.